Tecan Group AG (TCHBF)

Market Cap	2.59B
Revenue (ttm)	1.03B
Net Income (ttm)	74.67M
Shares Out	n/a
EPS (ttm)	5.84
PE Ratio	34.69
Forward PE	21.34
Dividend	3.68 (1.84%)
Ex-Dividend Date	Apr 14, 2025

Volume	20
Average Volume	497
Open	200.00
Previous Close	n/a
Day's Range	200.00 - 200.00
52-Week Range	182.45 - 340.27
Beta	0.97
RSI	33.26
Earnings Date	Jun 12, 2025

About Tecan Group AG

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized O...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1980
• Employees: 3,341
• Stock Exchange: OTCMKTS
• Ticker Symbol: TCHBF

Financial Performance

In 2024, Tecan Group AG's revenue was 934.28 million, a decrease of -13.04% compared to the previous year's 1.07 billion. Earnings were 67.66 million, a decrease of -48.77%.

Financial numbers in CHF